Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 480 M530 M534 M529 M466 M556 M 2.08 B Research & development —————— — Operating income 320 M197 M229 M268 M379 M239 M 1.11 B Non-Operating Income, Total -14 M-15 M12 M15 M-12 M-26 M -11 M Interest expense, net of interest capitalized 19 M19 M19 M19 M23 M23 M 84 M Non-Operating Income, excl. Interest Expenses -33 M-34 M-7 M-4 M-35 M-49 M -95 M Unusual income/expense —————— — Pretax income 469 M369 M372 M467 M1.09 B405 M 2.34 B Equity in earnings 1 M13 M-6 M27 M22 M18 M 61 M Taxes 65 M43 M55 M53 M80 M48 M 236 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 255 M154 M174 M215 M299 M191 M 879 M Discontinued operations —————— — Net income 255 M154 M174 M215 M299 M191 M 879 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 255 M154 M174 M215 M299 M191 M 879 M Basic earnings per share (Basic EPS) 3.031.842.072.583.592.29 10.53 Diluted earnings per share (Diluted EPS) 3.031.842.072.583.592.29 10.53 Average basic shares outstanding 83.9 M83.8 M83.5 M83.4 M83.5 M83.3 M — Diluted shares outstanding 83.9 M83.8 M83.5 M83.4 M83.5 M83.3 M — EBITDA 410 M284 M308 M346 M452 M320 M 1.43 B EBIT 390 M279 M303 M341 M432 M315 M 1.39 B Cost of revenue 1.18 B965 M1.01 B1.35 B1.06 B906 M 4.33 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 20 M5 M5 M5 M20 M5 M 35 M